Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer

[1]  P. Dasgupta,et al.  National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer. , 2017, International journal of radiation oncology, biology, physics.

[2]  G. Sanguineti,et al.  Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Kuban,et al.  Patient-reported Urinary, Bowel, and Sexual Function After Hypofractionated Intensity-modulated Radiation Therapy for Prostate Cancer: Results From a Randomized Trial , 2016, American journal of clinical oncology.

[4]  B. Heijmen,et al.  Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial. , 2016, The Lancet. Oncology.

[5]  S. Arcangeli,et al.  Hypofractionated radiotherapy for organ-confined prostate cancer: is less more? , 2016, Nature Reviews Urology.

[6]  J. Lebesque,et al.  Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts. , 2016, International journal of radiation oncology, biology, physics.

[7]  Qiong-wen Zhang,et al.  The Effectiveness of Intensity Modulated Radiation Therapy versus Three-Dimensional Radiation Therapy in Prostate Cancer: A Meta-Analysis of the Literatures , 2016, PloS one.

[8]  E. Horwitz,et al.  Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. , 2015, International journal of radiation oncology, biology, physics.

[9]  A. D'Amico,et al.  A systematic review of hypofractionation for primary management of prostate cancer. , 2015, European urology.

[10]  D. Dearnaley,et al.  8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group , 2015 .

[11]  R. Orecchia,et al.  Image-Guided Radiotherapy for Prostate Cancer using 3 Different Techniques: Localization Data of 186 Patients , 2015, Tumori.

[12]  Marnix G Witte,et al.  Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients. , 2015, International journal of radiation oncology, biology, physics.

[13]  R. Orecchia,et al.  Planning study to compare dynamic and rapid arc techniques for postprostatectomy radiotherapy of prostate cancer , 2014, Strahlentherapie und Onkologie.

[14]  P. Jean-Pierre,et al.  Treatment-related Side Effects And Quality Of Life Among Prostate Cancer Patients Treated With Conventional versus Hypofractionated Intensity Mediated Radiotherapy: A Phase III Hypofractionation Trial , 2011 .

[15]  R. Orecchia,et al.  Acute toxicity of image-guided hypofractionated radiotherapy for prostate cancer: nonrandomized comparison with conventional fractionation. , 2011, Urologic oncology.

[16]  Anthony Fyles,et al.  Long-term results of hypofractionated radiation therapy for breast cancer. , 2010, The New England journal of medicine.

[17]  M. Ritter Rationale, conduct, and outcome using hypofractionated radiotherapy in prostate cancer. , 2008, Seminars in radiation oncology.

[18]  Cristina Garibaldi,et al.  Dose escalation for prostate cancer using the three-dimensional conformal dynamic arc technique: analysis of 542 consecutive patients. , 2008, International journal of radiation oncology, biology, physics.

[19]  Alexandra L Hanlon,et al.  What dose of external-beam radiation is high enough for prostate cancer? , 2007, International journal of radiation oncology, biology, physics.

[20]  R. Orecchia,et al.  Dose distribution in 3-dimensional conformal radiotherapy for prostate cancer: comparison of two treatment techniques (six coplanar fields and two dynamic arcs). , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  Paul Schellhammer,et al.  Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. , 2006, International journal of radiation oncology, biology, physics.

[22]  C. Ma,et al.  Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. , 2006, International journal of radiation oncology, biology, physics.

[23]  C. Reddy,et al.  Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an independent predictor of outcome. , 2003, International journal of radiation oncology, biology, physics.

[24]  Roberto Orecchia,et al.  Finding dose-volume constraints to reduce late rectal toxicity following 3D-conformal radiotherapy (3D-CRT) of prostate cancer. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Patrick A. Kupelian,et al.  Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer: Cleveland Clinic experience. , 2007, International journal of radiation oncology, biology, physics.

[26]  F. Vicini,et al.  Defining a dose-response relationship with radiotherapy for prostate cancer: is more really better? , 2001, International journal of radiation oncology, biology, physics.

[27]  S. L. Morgan-Fletcher Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), ICRU Report 62. ICRU, pp. ix+52, 1999 (ICRU Bethesda, MD) $65.00 ISBN 0-913394-61-0 , 2001 .

[28]  W. De Gersem,et al.  Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. , 2000, International journal of radiation oncology, biology, physics.

[29]  C C Ling,et al.  Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  T. Pajak,et al.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.

[31]  R. Stoyanova,et al.  Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[33]  N. Dubrawsky Cancer statistics , 2022 .